Ausgabe 11/2020
Inhalt (32 Artikel)
Tocilizumab for the treatment of TAFRO syndrome: a systematic literature review
Mitsuhiro Akiyama, Yuko Kaneko, Tsutomu Takeuchi
Risk factors associated with increased emergency department utilization in patients with sickle cell disease: a systematic literature review
Samir K. Ballas, Carlton Dampier
Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries
Rishi J. Desai, Mufaddal Mahesri, Denise Globe, Alex Mutebi, Rhonda Bohn, Maureen Achebe, Raisa Levin, Sebastian Schneeweiss
Hepatic and cardiac iron load as determined by MRI T2* in patients with congenital dyserythropoietic anemia type I
Mahdi Asleh, Aviva Levitas, Sharon Daniel, Abed Abu-Quider, Miriam Ben-Harosh, Joseph Kapelushnik
Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center
José Carlos Jaime-Pérez, Patrizia Aguilar-Calderón, Raúl A. Jiménez-Castillo, Eugenia M. Ramos-Dávila, Lorena Salazar-Cavazos, David Gómez-Almaguer
Prevalence of anaemia and associated risk factors amongst The Malaysian Cohort participants
Noraidatulakma Abdullah, Norliza Ismail, Nazihah Abd Jalal, Farazela Mohd Radin, Raihannah Othman, Azwa Shazwani Kamalul Arifin, Mohd Arman Kamaruddin, Rahman Jamal
Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation
Beatrice Drexler, Felicitas Zurbriggen, Tamara Diesch, Romaine Viollier, Joerg P. Halter, Dominik Heim, Andreas Holbro, Laura Infanti, Andreas Buser, Sabine Gerull, Michael Medinger, André Tichelli, Jakob R. Passweg
Very-low-dose decitabine treatment for patients with intermediate- or high-risk myelodysplastic syndrome: a retrospective analysis of thirteen cases
Kaiji Zhang, Ying Lian, Xiaohong Guan, Qian Hu, Lihua Lei, Li Tao, Dong He, Juan Lin, Zheng Hou, Lirong Ren, Xiaoxiao Liu, Qian Ren, Lin Pan, Xiaoli Fei, Mei Xiong, Shunzhu Wen, Jinzhu Cao
Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy
Olivier Ballo, Eva-Maria Kreisel, Fagr Eladly, Uta Brunnberg, Jan Stratmann, Peter Hunyady, Michael Hogardt, Thomas A. Wichelhaus, Volkhard A. J. Kempf, Björn Steffen, Joerg J. Vehreschild, Maria J. G. T. Vehreschild, Fabian Finkelmeier, Hubert Serve, Christian H. Brandts
Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States
Srdan Verstovsek, Jingbo Yu, Jonathan K. Kish, Dilan Paranagama, Jill Kaufman, Callan Myerscough, Michael R. Grunwald, Philomena Colucci, Ruben Mesa
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience
Huseyin Bekoz, Murat Ozbalak, Nuri Karadurmus, Semra Paydas, Alev Turker, Tayfur Toptas, Tülin Firatli Tuglular, Fevzi Altuntas, Merih Kizil Cakar, Mehmet Sonmez, Zafer Gulbas, Nazlı Demir, Leylagul Kaynar, Rahsan Yildirim, Ihsan Karadogan, Mutlu Arat, Irem Kapucu, Nevin Alayvaz Aslan, Vildan Ozkocaman, Mehmet Turgut, Meltem Kurt Yuksel, Muhit Ozcan, Sibel Kabukcu Hacioglu, Ibrahim Barista, Metin Demirkaya, Guray Saydam, Selami K. Toprak, Mehmet Yilmaz, Onur Demirkol, Burhan Ferhanoglu
Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities
Norina Tanaka, Yoichi Imai, Kentaro Yoshinaga, Masayuki Shiseki, Junji Tanaka
Correction to: Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities
Norina Tanaka, Yoichi Imai, Kentaro Yoshinaga, Masayuki Shiseki, Junji Tanaka
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study
Jing Li, Li Bao, Zhongjun Xia, Sili Wang, Xin Zhou, Kaiyang Ding, Wenhao Zhang, Wei Yang, Bingzong Li, Chengcheng Fu, Bing Chen, Luoming Hua, Liang Wang, Jun Luo, Yang Yang, Tianhong Xu, Weida Wang, Yun Huang, Guolin Wu, Peng Liu
Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response
Svitlana Demyanets, Alexandra Kaider, Ingrid Simonitsch-Klupp, Günther Bayer, Almira Subasic, Renate Thalhammer, Harald Esterbauer, Maria T. Krauth, Hermine Agis, Thomas Reiter, Ilse Schwarzinger
Detection of EP300-ZNF384 fusion in patients with acute lymphoblastic leukemia using RNA fusion gene panel sequencing
Yu Jing, Yan-Fen Li, Hua Wan, Dai-Hong Liu
Association of three factors (ABCB1 gene expression, steroid response, early response at day + 8) on the response to induction in patients with acute lymphoblastic leukemia
Christian Ramos-Peñafiel, Irma Olarte-Carrillo, Rafael Cerón Maldonado, Adrián de la Cruz Rosas, Juan Collazo-Jaloma, Adolfo Martínez-Tovar
Incidence, risk factors and outcome of extramedullary relapse after allogeneic hematopoietic stem cell transplantation in patients with adult acute lymphoblastic leukemia
Jian Yu, Xinyi Ge, Yi Luo, Jimin Shi, Yamin Tan, Xiaoyu Lai, Yanmin Zhao, Yishan Ye, Yuanyuan Zhu, Weiyan Zheng, He Huang
A retrospective analysis on anti-CD20 antibody–treated Epstein–Barr virus–related posttransplantation lymphoproliferative disorder following ATG-based haploidentical T-replete hematopoietic stem cell transplantation
Xue-Yi Luo, Xiao-Dong Mo, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Kai-Yan Liu, Ying-Jun Chang, Xiang-Yu Zhao, Xiao-Jun Huang
Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation
Xing-Ye Meng, Hai-Xia Fu, Xiao-Lu Zhu, Jing-Zhi Wang, Xiao Liu, Chen-Hua Yan, Yuan-Yuan Zhang, Xiao-Dong Mo, Yu Wang, Wei Han, Yu-Hong Chen, Ding-Bao Chen, Hui-Xin Liu, Ying-Jun Chang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Hui Zhang
Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country
Ahmet Murt, Tugrul Elverdi, Ahmet Emre Eskazan, Ayse Salihoglu, Muhlis Cem Ar, Seniz Ongoren, Zafer Baslar, Teoman Soysal
Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia
Fei Gao, Xiaoyu Zhou, Jimin Shi, Yi Luo, Yamin Tan, Huarui Fu, Xiaoyu Lai, Jian Yu, He Huang, Yanmin Zhao
Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
Alexander Solms, Anita Shah, Erik Berntorp, Andreas Tiede, Alfonso Iorio, Camila Linardi, Maurice Ahsman, Maria Elisa Mancuso, Tihomir Zhivkov, Toshko Lissitchkov
A case of allogeneic hematopoietic stem cell transplantation for primary plasma cell leukemia after treatment with daratumumab
Yoshihito Horisawa, Tadakazu Kondo, Masakatsu Hishizawa, Kouhei Yamashita, Akifumi Takaori-Kondo
Residual disease by flow cytometry in patients with nucleophosmin-mutated acute myeloblastic leukemia
Mengge Gao, Xiaosu Zhao
Myelomatous pleural effusion with plasmablastic morphology and high genetic complexity as isolated extramedullary relapse
Fernando Martín-Moro, Andrés Roncancio, Amparo Benito, María Talavera, Jesús Villarrubia, María J Blanchard
Expansion of paroxysmal nocturnal hemoglobinuria clones in MPLW515L mutation harboring primary myelofibrosis
Keita Kirito
Atypical presentation of a central nervous system aspergillosis in a peripheral T cell lymphoma patient
Mathieu Larroquette, Nahéma Issa, Frédéric Gabriel, Fabrice Camou
A case of “double hit” mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib
Greta Scapinello, Marcello Riva, Antonio Branca, Marco Pizzi, Laura Bonaldi, Annalisa Martines, Sabrina Manni, Andrea Visentin, Livio Trentin, Gianpietro Semenzato, Carmela Gurrieri, Francesco Piazza
Biallelic rare 17 bp deletion mutation (HBB:c.380_396 del TGCAGGCTGCCTATCAG) in a transfusion depended form of thalassemia
Poonam Tripathi, Sarita Agarwal, Anshul Gupta, Kausik Mandal